BAYRY
Price
$5.87
Change
+$0.04 (+0.69%)
Updated
Apr 3 closing price
Capitalization
57.55B
39 days until earnings call
SNY
Price
$54.62
Change
+$0.67 (+1.24%)
Updated
Apr 3 closing price
Capitalization
122.61B
20 days until earnings call
Ad is loading...

BAYRY vs SNY

Header iconBAYRY vs SNY Comparison
Open Charts BAYRY vs SNYBanner chart's image
Bayer A.G
Price$5.87
Change+$0.04 (+0.69%)
Volume$615.05K
Capitalization57.55B
Sanofi ADS
Price$54.62
Change+$0.67 (+1.24%)
Volume$1.84M
Capitalization122.61B
BAYRY vs SNY Comparison Chart
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. SNY commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a Hold and SNY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BAYRY: $5.87 vs. SNY: $54.62)
Brand notoriety: BAYRY and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 85% vs. SNY: 71%
Market capitalization -- BAYRY: $57.55B vs. SNY: $122.61B
BAYRY [@Pharmaceuticals: Major] is valued at $57.55B. SNY’s [@Pharmaceuticals: Major] market capitalization is $122.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileSNY’s FA Score has 2 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • SNY’s FA Score: 2 green, 3 red.
According to our system of comparison, SNY is a better buy in the long-term than BAYRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 4 TA indicator(s) are bullish while SNY’s TA Score has 5 bullish TA indicator(s).

  • BAYRY’s TA Score: 4 bullish, 5 bearish.
  • SNY’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, SNY is a better buy in the short-term than BAYRY.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а -4.40% price change this week, while SNY (@Pharmaceuticals: Major) price change was -0.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.76%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -8.15%.

Reported Earning Dates

BAYRY is expected to report earnings on May 13, 2025.

SNY is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.76% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNY($123B) has a higher market cap than BAYRY($57.5B). SNY has higher P/E ratio than BAYRY: SNY (20.80) vs BAYRY (17.04). BAYRY YTD gains are higher at: 20.287 vs. SNY (13.249). SNY (12.6B) and BAYRY (12.1B) have comparable annual earnings (EBITDA) . SNY has more cash in the bank: 8.98B vs. BAYRY (7.98B). BAYRY has higher revenues than SNY: BAYRY (50.5B) vs SNY (46.4B).
BAYRYSNYBAYRY / SNY
Capitalization57.5B123B47%
EBITDA12.1B12.6B96%
Gain YTD20.28713.249153%
P/E Ratio17.0420.8082%
Revenue50.5B46.4B109%
Total Cash7.98B8.98B89%
Total DebtN/A18.4B-
FUNDAMENTALS RATINGS
BAYRY vs SNY: Fundamental Ratings
BAYRY
SNY
OUTLOOK RATING
1..100
7773
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10036
SMR RATING
1..100
9278
PRICE GROWTH RATING
1..100
6050
P/E GROWTH RATING
1..100
8432
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (12) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (66) in the null industry. This means that SNY’s stock grew somewhat faster than BAYRY’s over the last 12 months.

SNY's Profit vs Risk Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (100) in the null industry. This means that SNY’s stock grew somewhat faster than BAYRY’s over the last 12 months.

SNY's SMR Rating (78) in the Pharmaceuticals Major industry is in the same range as BAYRY (92) in the null industry. This means that SNY’s stock grew similarly to BAYRY’s over the last 12 months.

SNY's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as BAYRY (60) in the null industry. This means that SNY’s stock grew similarly to BAYRY’s over the last 12 months.

SNY's P/E Growth Rating (32) in the Pharmaceuticals Major industry is somewhat better than the same rating for BAYRY (84) in the null industry. This means that SNY’s stock grew somewhat faster than BAYRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYSNY
RSI
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
28%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
46%
Momentum
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
44%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
47%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
41%
Advances
ODDS (%)
Bullish Trend 8 days ago
59%
Bullish Trend 8 days ago
55%
Declines
ODDS (%)
Bearish Trend 12 days ago
70%
Bearish Trend 3 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
53%
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
48%
View a ticker or compare two or three
Ad is loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACCOX9.56N/A
N/A
American Century International Val C
TVIRX73.21N/A
N/A
Thornburg Small/Mid Cap Core R4
JCMAX60.11N/A
N/A
JPMorgan Mid Cap Equity A
MELSX14.41N/A
N/A
Morgan Stanley Inst EMkts Ldrs R6
FSZZX9.11N/A
N/A
Fidelity Advisor Sustainable EM Eq Z

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
+0.69%
BAYZF - BAYRY
88%
Closely correlated
+2.29%
OPHLY - BAYRY
23%
Poorly correlated
+0.58%
SNY - BAYRY
23%
Poorly correlated
+1.24%
AZN - BAYRY
21%
Poorly correlated
+2.35%
BIIB - BAYRY
20%
Poorly correlated
-0.46%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+1.24%
SNYNF - SNY
61%
Loosely correlated
-0.44%
GSK - SNY
41%
Loosely correlated
+3.64%
AZN - SNY
39%
Loosely correlated
+2.35%
NVS - SNY
39%
Loosely correlated
+1.35%
JNJ - SNY
35%
Loosely correlated
+2.87%
More